ReviewFrontiers in immunology2022

T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation.

Pierre Gaudeaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.